BRIEF-Albany Molecular Research prices $130 mln cash convertible senior notes

Wed Nov 20, 2013 7:16am EST

Nov 20 (Reuters) - Albany Molecular Research Inc : * Amri announces pricing of $130 million cash convertible senior notes * Says also granted initial purchasers of notes option to purchase up to an

additional $20.0 million principal amount of notes * Says initial strike price of the cash convertible note hedge transactions is

about $15.63 per share * Also entered into warrant transactions with option counterparties, with

initial strike price of about $18.94 per share * Says expects to use portion of net proceeds to pay the cost of the cash

convertible note hedge transactions * Source text for Eikon * Further company coverage

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.